ISRGIntuitive Surgical
Is the price fair?
Neither cheap nor expensive: nothing decisive, though rich vs its sector.
Priced for ~16% a year FCF growth. Roughly in line with its three-year revenue growth of 18% a year.
In its normal range: P/E 48.6 vs a 55.9 median over 41 quarters (−13% vs median).
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What ISRG's price assumes
Intuitive Surgical trades at 48.6× earnings against 39.6× for the median Medical Instruments & Supplies name, more expensive than its own group.
Trailing P/E · Medical Instruments & Supplies median 39.6 · 1.23× the median: the market pays up for this one
- Price / sales
- 14.3
Price / sales · today's price, fiscal year to Dec 31, 2025
- Free cash flow yield
- 2.2%
Free cash flow yield · Medical Instruments & Supplies median 3.4%
- Growth the price implies
- +16%
Growth the price implies · The price pays for +16% free cash flow growth a year for a decade; the business has delivered +40% a year over the last three.
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 8.08
- EV / EBITtoday's price, fiscal year to Dec 31, 2025
- 46.9
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 13.7
- Healthcare median P/E509 names
- 26.2
- Medical Instruments & Supplies median P/E33 names
- 39.6
- Free cash flow, trailing twelve months
- $3.22B
- Market capitalisation
- $144.1B
- 3-year revenue growth
- +18%
- 3-year free cash flow growth
- +40%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $388.96 |
| Its own P/E history, median | $487.84 |
| Its own P/E history, upper quartile | $626.73 |
| 52-week range | $332.42 – $592.85 |
| Today | $423.91 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
The closest names by size in the same industry